PHR Form 144 Filed for 7,746-Share Sale on NYSE

Rhea-AI Filing Summary

Form 144 notice for Phreesia, Inc. (PHR) shows a proposed sale of 7,746 common shares with an aggregate market value of $251,476.45, to be sold through Fidelity Brokerage Services on the NYSE on 08/28/2025. The shares were acquired via stock options granted on 01/31/2018 and 03/27/2019 and payment is listed as cash. The filing also lists recent sales by the same person totaling 95,418 shares on 07/17/2025 and 08/27/2025 with gross proceeds of $3,045,686.16 combined. The filer attests there is no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider Rule 144 sale; transaction size appears immaterial to market capitalization.

The filing documents a proposed Rule 144 sale of 7,746 common shares by a person associated with the issuer, executed through a broker on 08/28/2025. Shares originate from option grants in 2018 and 2019 and are to be paid in cash. Recent historical sales by the same person total 95,418 shares with disclosed gross proceeds. For investors, this is a compliance disclosure of insider liquidity rather than an operational development. Absent additional context on insider holdings or planned future sales, the disclosure itself is neutral.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; affirms representation of no undisclosed material information.

The Form 144 provides required transparency around an insider sale and includes the signer’s attestation regarding material information and any Rule 10b5-1 plan reliance fields. It confirms the mechanics of acquisition (options) and broker execution details. This document supports regulatory transparency and does not, on its face, indicate governance concerns beyond routine insider liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7746	251476.45	59504269	08/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Options Granted - 01/31/2018	Issuer			1833	08/28/2025	Cash
Common	08/28/2025	Options Granted - 03/27/2019	Issuer			5913	08/28/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	3171	85254.87
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/27/2025	92247	2953431.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 filed on 08/28/2025 disclose?

The filing discloses a proposed Rule 144 sale of 7,746 common shares with aggregate market value of $251,476.45 to be sold through Fidelity on the NYSE on 08/28/2025.

Who acquired the shares being sold according to the filing?

The shares were acquired via options granted on 01/31/2018 and 03/27/2019 and are to be sold for cash.

Has the seller recently sold other Phreesia shares?

Yes. The filing lists sales of 3,171 shares on 07/17/2025 for $85,254.87 and 92,247 shares on 08/27/2025 for $2,953,431.29.

Through which broker will the proposed sale be executed?

The sale is to be executed through Fidelity Brokerage Services LLC, with execution on the NYSE.

Does the filer attest to the absence of undisclosed material information?

Yes. The person for whose account the securities will be sold represents by signing that they do not know any undisclosed material adverse information.